Bio-Rad Laboratories (BIO) Total Non-Current Liabilities (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Total Non-Current Liabilities of $2.7 billion for Q1 2026, up 2.46% year-over-year from $2.7 billion in Q1 2025, and down 6.28% quarter-over-quarter from $2.9 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Total Non-Current Liabilities for 18 consecutive years, with $2.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 2.46% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $2.7 billion (up 2.46% YoY), while the FY2025 annual figure was $2.9 billion, up 11.7% from the prior year.
- Total Non-Current Liabilities retreated to $2.7 billion in Q1 2026 per BIO's latest filing, from $2.9 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $4.0 billion in Q1 2022 and bottomed at $2.6 billion in Q4 2024.
- Historically, Total Non-Current Liabilities has averaged $3.2 billion across 5 years, with a median of $3.3 billion in 2023.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 29.58% in 2022 and fell as far as 22.85% in 2022.
- Bio-Rad Laboratories' Total Non-Current Liabilities stood at $3.7 billion in 2022, then decreased by 8.88% to $3.4 billion in 2023, then decreased by 22.16% to $2.6 billion in 2024, then gained by 11.7% to $2.9 billion in 2025, then decreased by 6.28% to $2.7 billion in 2026.
- Business Quant data shows BIO's Total Non-Current Liabilities at $2.7 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Bio-Rad Laboratories | 10.23 Bn | 8.61 Bn | 345.80 Mn | 2.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Bn |
| Mar 31, 2026 | 2.74 Bn |
| Dec 31, 2025 | 2.92 Bn |
| Sep 30, 2025 | 2.75 Bn |
| Jun 30, 2025 | 2.88 Bn |
| Mar 31, 2025 | 2.67 Bn |
| Dec 31, 2024 | 2.62 Bn |
| Sep 30, 2024 | 2.92 Bn |
| Jun 30, 2024 | 2.72 Bn |
| Mar 31, 2024 | 3.37 Bn |
| Dec 31, 2023 | 3.36 Bn |
| Sep 30, 2023 | 3.29 Bn |
| Jun 30, 2023 | 3.33 Bn |
| Mar 31, 2023 | 3.70 Bn |
| Dec 31, 2022 | 3.69 Bn |
| Sep 30, 2022 | 3.40 Bn |
| Jun 30, 2022 | 3.58 Bn |
| Mar 31, 2022 | 4.01 Bn |
| Dec 31, 2021 | 3.93 Bn |
| Sep 30, 2021 | 4.41 Bn |